#10 - Shawn Singh - Tackling Anxiety & Depression: A Unique New Approach with a Fraction of the Side Effects

10/13/20 • 54 min

Everyone's dealt with anxiety and depression to some extent, at some point in their lives. It can be debilitating and can cause feelings of hopelessness and helplessness.
My guest, Shawn Singh wants to change that. Him and his company, Vistagen Therapeutics are taking on anxiety and depression with their unique bio technology that aims to leave the nasty side effects of anxiety and depression meds behind
Vistagen Therapeutics is a publicly traded company on the Nasdaq stock exchange under the ticket VTGN.
If you are someone who's dealt with either anxiety or depression this episode is for you.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/shawn-singh-vistagen-therapeutics

-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

Previous Episode

#9 - Brian Culley - Cell Therapy & The Power of Pluripotent Stem Cells

Imagine being blind and you can see again. Imagine being paralyzed and you can move again. Imagine how amazing it would feel to be cured of cancer. Life changing would be an understatement. My guest today is the CEO of a company that is leading the way in cell therapy, a technology that can do just that; cure the blind, give movement to the paralyzed, and cure cancer. Brian Culley is the CEO of Lineage Cell Therapeutics, a publicly traded company on the NYSE. Stock ticker: LCTX
Lineage Cell Therapeutics has had some extremely promising results by using the power of Pluripotent stem cells. This was a fascinating and exciting conversation and Brian does a great job of explaining complicated subjects so the average person can understand.
If you're curious about the almost magic like power of Pluripotent stem cells, and all that they can do, than this is a must listen.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/brian-culley-lineage-cell-therapeutics

-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

Next Episode

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Imagine if you could turn the characteristics of a cell on and off... or up and down like a volume trigger... constantly tuning things until everything is working just right. It might sound impossible, but that’s exactly what Obsidian therapeutics is working on.
I’ll admit, it was tough for me to wrap my mind around this one at first, but my guest today did a fantastic job of explaining things. So without further ado, chief development officer of Obsidian therapeutics, Catherine Stehman-Breen.
Podcast notes and transcript available here: https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics

-James Ruhle, SimpleBioTechPodcast.com
Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech
If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle

The Simple BioTech Podcast - #10 - Shawn Singh - Tackling Anxiety & Depression: A Unique New Approach with a Fraction of the Side Effects

Transcript

Speaker 100:00:00.989

Feelings of anxiety and depression can be absolutely debilitating. And the side effects of the medication that's supposed to make you feel better. Can I Ronica often make things worse?

Speaker 100:00:15.630

It's amazing that in 2020, we haven't really figured out a consistent, reliable and side effect, free method of dealing with these issues. My guest today is the CEO of a company that is tackling these incredibly